Publications

5891 Results

Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a Children's Oncology Group and Southwest Oncology Group Study [PMID21873548; PMC3208275]

Authors
P Ho;K Kopecky;T Alonzo;R Gerbing;K Miller;J Kuhn;R Ries;S Raimondi;B Hirsch;V Oehler;C Hurwitz;J Franklin;A Gamis;S Petersdorf;J Anderson;J Godwin;G Reaman;C Willman;I Bernstein;J Radich;F Appelbaum;D Stirewalt
Journal / Conference
Blood 118(17):4561-4566
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031, SWOG-9500

Incidence of therapy-related myeloid neoplasia after initial for CLL with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US intergroup study E2997 [PMID21803850; PMC3186330]

Authors
MR Smith;D Neuberg;IW Flynn;MR Grever;HM Lazarus;JM Rowe;G Dewald;JM Bennett;E Paietta;JC Byrd;MA Hussein;FR Appelbaum;RA Larson;MR Litzow;MS Tallman
Journal / Conference
Blood 118(13):3525-3527
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
E2997

p53 expression in node-positive breast cancer patients: results from the cancer and leukemia group B 9344 trial (159905) [PMID21693655; PMC3149770]

Authors
JF Lara;LG Dressler;G Broadwater;IJ Bleiweiss;S Edgerton;D Cowan;L Goldstein;S Martino;J Ingle;IC Henderson;L Norton;E Winer;C Hudis;MJ Ellis;DA Berry;DF Hayes
Journal / Conference
Clinical Cancer Research 17(15):5170-5178
Year
2011
Research Committee(s)
Breast
Study Number(s)
SWOG-9410 (INT-0148) (CALGB-9344)

Benchmarks for evaluating phase II clinical trials in stage IV melanoma: the recent SWOG experience

Authors
V Sondak;M Othus;L Flaherty;B Redman;J Moon;K Margolin;C Lao;W Carson;A Ribas
Journal / Conference
International Melanoma Congress, abstract 50; 8th Annual Meeting, Nov 9-11, 2011, Tampa, Fl; oral presentation
Year
2011
Research Committee(s)
Melanoma
Study Number(s)
S0026, S0438, S0508, S0512, S0826

SWOG S0120 observational trial for MGUS and asymptomatic multiple myeloma (AMM): imaging predictors of progression for patients treated at UAMS

Authors
C Heuck;R Sexton;M Dhodapkar;Q Zhang;S Usmani;B Nair;F van Rhee;A Hoering;J Crowley;J Shaughnessy;R Orlowski;B Barlogie
Journal / Conference
Blood 118(21):abst 3955; American Society of Hematolgy, poster presentation
Year
2011
Research Committee(s)
Myeloma
Study Number(s)
S0120

A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK intercontinental trial CRUKE/01/013

Authors
JM Crook;CJ O'Callaghan;K Ding;G Duncan;D Dearnaley;C Higano;E Horwitz;E Frymire;S Malone;J Chin;A Nabid;P Warde;T Corbett;S Angyalfi;SL Goldenberg;M Gospodarowicz;J Loque;P Shellhammer;F Saad;L Klotz
Journal / Conference
Journal of Clinical Oncology 29:(suppl; abstr 4514); ASCO oral presentation
Year
2011
Research Committee(s)
Genitourinary
Study Number(s)
JPR7

Systemic evaluation of the impact of disease progression (DP) date determination on progression-free survival (PFS) in advanced lung cancer: a joint North Central Cancer Treatment Group (NCCTG) and Southwest Oncology Group (SWOG) investigation

Authors
SJ Mandrekar;Y Qi;K Allen-Ziegler;SL Hillman;M Redman;SE Schild;D Gandara;A Adjei
Journal / Conference
Journal of Clinical Oncology 29:(suppl 4: abstr 2); ASCO oral presentation
Year
2011
Research Committee(s)
Lung

Phase II trial of cisplatin plus etoposide plus gemcitabine plus solumedrol (PEGS) in peripheral T-cell non-Hodgkin lymphoma (SWOG S0350)

Authors
D Mahadevan;J Unger;D Persky;C Spier;F Young;M LeBlanc;RI Fisher;TP Miller
Journal / Conference
International Conference on Malignant Lymphoma, 11th annual meeting, oral presentation
Year
2011
Research Committee(s)
Lymphoma
Study Number(s)
S0350

Prediction of early death following induction therapy for newly diagnosed acute leukemia with pretreatment risk scores: a novel paradigm for treatment assignment

Authors
R Walter;M Othus;G Borthakur;F Ravandi;J Cortes;S Pierce;F Appelbaum;H Kantarjian;E Estey
Journal / Conference
Journal of Clinical Oncology, 29(33):4417-23;
Year
2011
Research Committee(s)
Leukemia
PMID
PMID21969499
PMC
PMC3221524
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918

A gene expression signature in diagnostic formalin fixed paraffin embedded tissue predicts overall survival in locally advanced and advanced stage classical hodgkin lymphoma - a correlative study from the E2496 intergroup trial

Authors
DW Scott;FC Chan;S Rojic;K Tan;B Meissner;P Farinha;S Horning;RI Fisher;NL Bartlett;LE Shepherd;JM Connors;AB de Sousa;BS Kahl;LI Gordon;C Steidl;RD Gascoyne
Journal / Conference
Blood 118(21):abstract 430; American Society of Hematology Annual Meeting, oral presentation;
Year
2011
Research Committee(s)
Lymphoma
Study Number(s)
E2496